Back
Ascendis Pharma AS Stock Price Chart
Sponsored
ASND
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
41
ASND
Ascendis Pharma AS
Last Price:
149.16
Seasonality Move:
6.54%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.6 | Buy |
20-day SMA: | 130.69 | Buy |
50-day SMA: | 132.91 | Buy |
200-day SMA: | 135.36 | Buy |
8-day EMA: | 133.29 | Buy |
20-day EMA: | 130.71 | Buy |
50-day EMA: | 131.94 | Buy |
200-day EMA: | 129.45 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 68.26 | Buy |
Chaikin Money Flow: | 280060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.33 - 143.31) | Buy |
Bollinger Bands (100): | (125.42 - 139.7) | Buy |
Ascendis Pharma AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 148.89 while ASND 8-day simple moving average is 126.60, which is a Buy signal.
- The stock price of ASND is 148.89 while Ascendis Pharma AS 20-day SMA is 130.69, which makes it a Buy.
- Ascendis Pharma AS 50-day simple moving average is 132.91 while ASND share price is 148.89, making it a Buy technically.
- ASND stock price is 148.89 and Ascendis Pharma AS 200-day simple moving average is 135.36, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a Sell
The current Ascendis Pharma AS [ASND] share price is $148.89. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
8.54B
Price in USD:
148.89
Share Volume:
826.69K
Ascendis Pharma AS 52-Week Range
52-Week High:
161.00
52-Week Low:
85.29
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?
The Ascendis Pharma AS stock price is 148.89 USD today. -
Will ASND stock go up or go down?
Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators -
Is Ascendis Pharma AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 148.89 while ASND 8-day exponential moving average is 133.29, which is a Buy signal.
- The stock price of ASND is 148.89 while Ascendis Pharma AS 20-day EMA is 130.71, which makes it a Buy.
- Ascendis Pharma AS 50-day exponential moving average is 131.94 while ASND share price is 148.89, making it a Buy technically.
- ASND stock price is 148.89 and Ascendis Pharma AS 200-day simple moving average is 129.45, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
- ASND Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting Ascendis Pharma AS is a Buy
- Ascendis Pharma AS Relative Strength Index (RSI) is 68.26, which suggest Ascendis Pharma AS is overbought
- The Bollinger Bands (25) for Ascendis Pharma AS is (121.33 - 143.31), which suggest Ascendis Pharma AS is a Buy
- The Bollinger Bands (100) for Ascendis Pharma AS is (125.42 - 139.7), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.